We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » J&J Gets Complete Response Letter for Nucynta ER NDA
J&J Gets Complete Response Letter for Nucynta ER NDA
October 8, 2010
Johnson & Johnson (J&J) will have to provide more information to the FDA regarding a formulation change for its pain drug Nucynta ER to gain approval, according to a complete response letter.